.Attribute Medication, Posted online: 03 September 2024 doi:10.1038/ s41591-024-03223-zThis Point of view requires introduction of clients with MASLD and size of liver results in cardio-- renal-- metabolic tests, when data suggest mechanistically probable advantages and clinical safety-- as well as describes points to consider for test concept and governing approval.